Kenyan researchers are set to begging the clinical trials for three possible Covid-19 cures.
A clinical trial is when the medicine is tried on human beings to determine if it is effective in treating a disease.
According to The Nation, medical researchers are seeking approvals to conduct the trials to determine whether an antiretroviral drug named Remdesivir can effectively be used to treat Covid-19 patients in Kenya.
The other two drugs include hydroxychloroquine and Lopinavir/ritonavir will also be tested to determine their effectiveness.
Principal investigator in the study Dr. Loice Achieng Ombajo, who heads the Infectious Disease Unit at Kenyatta National Hospital said:
“We’re still in that stage where you can’t tell what actually works. What we’re hoping to do in the country is something called a clinical trial. In a clinical trial, you take many patients and randomly allocate them to one treatment or another. There’s an equal chance of ending up with any of the drugs and we’ll give you that treatment and observe your response,”
According to Dr. Ombajo, her team’s submission has been approved by the Ethics Committee at the University of Nairobi and been reviewed by the Poisons and Pharmacies Board.
The researchers are now awaiting final approval by the Poisons and Pharmacies Board and the National Council of Science, Technology and Innovation (NACOSTI).